John R. Egan, an officer at NetScout Systems Inc, has filed to sell 14,500 shares of common stock. The shares are valued at approximately $475,373.07. This transaction is significant as it reflects ongoing changes in executive compensation strategies within the computer integrated systems design industry.
NetScout Systems Inc, incorporated in Delaware, operates in the services sector, specifically focusing on computer integrated systems design. The company is headquartered at 310 Littleton Road, Westford, MA, and trades on the NASDAQ under the SEC file number 000-26251.
The filing indicates that Egan's shares were acquired through a vesting of restricted stock unit awards. The exact nature of these awards has been part of NetScout's equity compensation plan, which aims to align executive interests with shareholder value.
According to the filing, Egan's transaction may affect other executives and employees who are part of similar compensation plans. As the industry evolves, competitors may watch this move closely as they navigate their own compensation frameworks.
The filing does not say what happens next.
Details of the Transaction
John R. Egan's filing indicates that the shares being sold were acquired through multiple vesting events of restricted stock unit awards. Specifically, Egan acquired 1,240 shares on September 7, 2011, 9,238 shares on August 21, 2012, and 4,022 shares on April 30, 2013, all granted as part of NetScout's equity compensation plan.
The approximate sale date for this transaction is noted as November 11, 2026, and the shares are being sold through Merrill Lynch, located at 225 Liberty Street, Floor 37, New York, NY.
Outstanding Shares
As of the filing date, NetScout Systems Inc has a total of 71,067,586 shares outstanding. This context may provide insights into the overall equity structure of the company and the potential impact of Egan's transaction on the market.
"Nothing to report on securities sold in the past three months," the filing states, indicating that Egan has not engaged in any other sales during this period.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










